A course of 4 treatments, spaced by 3-5 weeks. Each session takes about 20-30 minutes.
- The Patented Optimal Pulse Technology uses precise, intense broad-spectrum light to address the inflammation – one of the key underlining factors in dry eye disease due to Meibomian Gland Dysfunction (MGD).
- Backed by numerous clinical studies and is first and only IPL FDA approved for Dry Eye Management
- Reduces inflammatory mediators.
- Destroys the abnormal blood vessels that perpetuate inflammation.
- Improves tear breakup time. Significantly boost tear break-up time and decrease osmolarity.
- Restores Meibomian gland functionality.
- Decreases the population of Demodex mites, which stimulate infection and boost the bacterial load on eyelids.